Enabling Technologies Hub
BARDA Accelerator Network
Enabling the Development of Innovations in Drug Discovery and Development and Biomanufacturing to Improve Clinical Research and Care Coordination
BioTools Innovator VANGUARD is at the forefront of biomanufacturing innovation, enabling life science tools startups to develop solutions that improve drug discovery and development; increase speed, capacity, portability, and scalability; and improve clinical research and clinical care coordination. VANGUARD stands ready to support startups in deploying innovative medical countermeasures that enhance the United States’ readiness for public health emergencies.
VANGUARD is a joint initiative between BioTools Innovator, the world’s first-ever accelerator focused on life science research tools, and the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services.
BioTools Innovator VANGUARD Opportunities
BioTools Innovator VANGUARD consists of two programs, a wraparound Accelerator program as part of the core BioTools Innovator annual cohort, and a specialized product Development, Evaluation, and Validation (DEV) funding opportunity. Companies may apply to either or both programs.
The BARDA Accelerator Network
In Partnership with the Biomedical Advanced Research and Development Authority
The BARDA Accelerator Network aims to provide comprehensive support to health security innovators, startups and BARDA portfolio companies through wrap-around accelerator services, technical and business/commercialization expertise, and resources. The network will facilitate the rapid development, evaluation, validation and commercialization of medical countermeasures.
Learn more at the BARDA Accelerator Network.
The BARDA Accelerator Network aims to provide comprehensive support to health security innovators, startups and BARDA portfolio companies through wrap-around accelerator services, technical and business/commercialization expertise, and resources. The network will facilitate the rapid development, evaluation, validation and commercialization of medical countermeasures.
Learn more at the BARDA Accelerator Network.
BARDA Accelerator Network Hubs
The BARDA Accelerator Network, made up of five Hubs, is built to drive growth in the startup ecosystem by speeding up the creation and market entry of cutting-edge health security solutions. Each Hub sources promising early-stage innovations within their specialized technology areas and offers funding to evaluate the feasibility of these concepts and provides resources for commercialization, helping to fast-track product development and validation.
Enabling Technologies
BioTools Innovator VANGUARD is at the forefront of biomanufacturing innovation, enabling life science tools startups to develop solutions that improve drug discovery and development; increase speed, capacity, portability, and scalability; and improve clinical research and clinical care coordination.
Diagnostics & Medical Devices
The International Consortium for Research, Engineering, Acceleration of Technology Excellence (I-CREATE) Hub supports the development and acceleration of novel diagnostics and medical devices to detect, prevent, or respond to medical consequences that result from health security threats.
Special Populations
Focus on innovations that can improve the detection, diagnosis, treatment, and informed outcomes in pediatric/neonatal populations and immunocompromised populations to enable health equity solutions in traditionally underrepresented communities and low-resource settings.
Therapeutics and Vaccines
The Vaccine Innovations and Therapeutics Acceleration Launchpad (VITAL) Hub will support the development and acceleration of next-generation therapeutic and vaccine platforms and technologies.
Digital Health Tools
Enabling Technologies
BioTools Innovator VANGUARD is at the forefront of biomanufacturing innovation, enabling life science tools startups to develop solutions that improve drug discovery and development; increase speed, capacity, portability, and scalability; and improve clinical research and clinical care coordination.
Diagnostics & Medical Devices
The International Consortium for Research, Engineering, Acceleration of Technology Excellence (I-CREATE) Hub supports the development and acceleration of novel diagnostics and medical devices to detect, prevent, or respond to medical consequences that result from health security threats.
Digital Health Tools
Special Populations
Focus on innovations that can improve the detection, diagnosis, treatment, and informed outcomes in pediatric/neonatal populations and immunocompromised populations to enable health equity solutions in traditionally underrepresented communities and low-resource settings.
Therapeutics and Vaccines
The Vaccine Innovations and Therapeutics Acceleration Launchpad (VITAL) Hub will support the development and acceleration of next-generation therapeutic and vaccine platforms and technologies.